News
High-signal headlines only - macro events, earnings, M&A, regulatory. Listicles and analyst clickbait filtered out by default. Refreshed hourly.
141last 24h
874last 7d
144● bullish (7d)
99● bearish (7d)
214publishers
Zacks143d agoneutral
ImmunityBio to Report Q1 Earnings: What's in the Cards?IBRX's Q1 outlook rides on Anktiva's surging uptake, with preliminary revenues showing triple-digit growth ahead of its earnings report later this month.